Works by Xue, Sheng-Li

Results: 42

Epigenetic therapy with chidamide alone or combined with 5-azacitidine exerts antitumour effects on acute myeloid leukaemia cells in vitro.

Published in:

Oncology Reports, 2022, v. 47, n. 4, p. N.PAG, doi. 10.3892/or.2022.8277

By:

Li, Zheng;
Zhang, Jian;
Zhou, Min;
Li, Jin-Li;
Qiu, Qiao-Cheng;
Fu, Jian-Hong;
Xue, Sheng-Li;
Qiu, Hui-Ying

Publication type:

Article

Interdigitating dendritic cell sarcoma presenting simultaneously with acute myelomonocytic leukemia: report of a rare case and literature review.

Published in:

2013

By:

Jiang, Yi-Zhi;
Dong, Ning-Zheng;
Wu, De-Pei;
Xue, Sheng-Li

Publication type:

Report

Pattern and prognostic value of FLT3‐ITD mutations in Chinese de novo adult acute myeloid leukemia.

Published in:

Cancer Science, 2018, v. 109, n. 12, p. 3981, doi. 10.1111/cas.13835

By:

Liu, Song‐Bai;
Qiu, Qiao‐Cheng;
Bao, Xie‐Bing;
Ma, Xiao;
Li, Hong‐Zhi;
Liu, Yue‐Jun;
Chen, Su‐Ning;
Song, Yao‐Hua;
Wu, De‐Pei;
Xue, Sheng‐Li

Publication type:

Article

CAG regimen enables relapsed or refractory T-cell acute lymphocytic leukemia patients to achieve complete remission: A report of six cases.

Published in:

American Journal of Hematology, 2008, v. 83, n. 2, p. 167, doi. 10.1002/ajh.21066

By:

Xue, Sheng-Li;
Wu, De-Pei;
Sun, Ai-Ning;
Tang, Xiao-Wen

Publication type:

Article

Venetoclax with hypomethylating agents versus intensive chemotherapy in newly diagnosed acute myeloid leukemia with myelodysplasia related changes: A propensity score-matched analysis based on International Consensus Classification.

Published in:

2024

By:

Wan, Chao-Ling;
Liu, Yu-Qing;
Liu, Fang-Tong;
Huang, Yuan-Hong;
Cao, Han-Yu;
Huang, Si-Man;
Tan, Kai-Wen;
Ge, Shuai-Shuai;
Wang, Miao;
Liu, Mei-Jing;
Wang, Zi-Hao;
Li, Zheng;
Xue, Sheng-Li;
Dai, Hai-Ping

Publication type:

Letter

Efficacy and safety of cladribine, low-dose cytarabine and venetoclax in relapsed/refractory acute myeloid leukemia: results of a pilot study.

Published in:

Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-00982-3

By:

Li, Yan-Yan;
Ge, Shuai-Shuai;
Huang, Yuan-Hong;
Xu, Ming-Zhu;
Wan, Chao-Ling;
Tan, Kai-Wen;
Tao, Tao;
Zhou, Hai-Xia;
Xue, Sheng-Li;
Dai, Hai-Ping

Publication type:

Article

Venetoclax plus hypomethylating agents in newly diagnosed acute myeloid leukemia patients with RUNX1::RUNX1T1: a retrospective propensity score matching study.

Published in:

Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00948-x

By:

Wang, Miao;
Cao, Han-Yu;
Tan, Kai-Wen;
Qiu, Qiao-Cheng;
Huang, Yuan-Hong;
Ge, Shuai-shuai;
Wang, Zi-Hao;
Chen, Jia;
Tang, Xiao-Wen;
Wu, De-Pei;
Xue, Sheng-Li;
Li, Zheng;
Dai, Hai-Ping

Publication type:

Article

Safety and efficacy of CD22 and CD19 CAR-T bridging auto-HSCT as consolidation therapy for AYA and adult B-ALL.

Published in:

Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00837-3

By:

Qiu, Yan;
Wan, Chao-Ling;
Xu, Ming-Zhu;
Zhou, Hai-Xia;
Liu, Mei-Jing;
Gong, Wen-Jie;
Kang, Li-Qing;
Sun, Ai-Ning;
Yu, Lei;
Wu, De-Pei;
Qian, Chong-Sheng;
Xue, Sheng-Li

Publication type:

Article

Safety and efficacy of CD22 and CD19 CAR-T bridging auto-HSCT as consolidation therapy for AYA and adult B-ALL.

Published in:

2023

By:

Qiu, Yan;
Wan, Chao-Ling;
Xu, Ming-Zhu;
Zhou, Hai-Xia;
Liu, Mei-Jing;
Gong, Wen-Jie;
Kang, Li-Qing;
Sun, Ai-Ning;
Yu, Lei;
Wu, De-Pei;
Qian, Chong-Sheng;
Xue, Sheng-Li

Publication type:

Letter

A Combined Histone Deacetylases Targeting Strategy to Overcome Venetoclax Plus Azacitidine Regimen Resistance in Acute Myeloid Leukaemia: Three Case Reports.

Published in:

Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.797941

By:

Wang, Bin-Ru;
Wan, Chao-Ling;
Liu, Song-Bai;
Qiu, Qiao-Cheng;
Wu, Tian-Mei;
Wang, Jun;
Li, Yan-Yan;
Ge, Shuai-Shuai;
Qiu, Yan;
Shen, Xiang-Dong;
Xue, Sheng-Li;
Li, Zheng

Publication type:

Article

A Phase II Trial of the Double Epigenetic Priming Regimen Including Chidamide and Decitabine for Relapsed/Refractory Acute Myeloid Leukemia.

Published in:

Frontiers in Oncology, 2021, v. 12, p. 1, doi. 10.3389/fonc.2021.726926

By:

Yin, Jia;
Wan, Chao-Ling;
Zhang, Ling;
Zhang, Hao;
Bai, Lian;
Zhou, Hai-Xia;
Xu, Ming-Zhu;
Chen, Li-Yun;
Qian, Chong-Sheng;
Qiu, Hui-Ying;
Chen, Su-Ning;
Tang, Xiao-Wen;
Wu, De-Pei;
Zhang, Yan-Ming;
Sun, Ai-Ning;
Xue, Sheng-Li

Publication type:

Article

Safe and potent anti‐CD19 CAR T‐cells with shRNA‐IL‐6 gene silencing element in patients with refractory or relapsed B‐cell acute lymphoblastic leukemia.

Published in:

HemaSphere, 2024, v. 8, n. 10, p. 1, doi. 10.1002/hem3.70007

By:

Ma, Jin‐Feng;
Yan, Jia‐Wei;
Liu, Mei‐Jing;
Yan, Chun‐Long;
Tang, Xiao‐Wen;
Qiu, Hui‐Ying;
Miao, Miao;
Han, Yue;
Li, Li‐Min;
Kang, Li‐Qing;
Xu, Nan;
Yu, Zhou;
Tan, Jing‐Wen;
Zhu, Hong‐Jia;
Jia, Xu;
Zhang, Zhi‐Zhi;
Wang, Miao;
Dai, Hai‐Ping;
Yu, Lei;
Xue, Sheng‐Li

Publication type:

Article

Patients with CML in the lymphoid blastic phase have inferior response to anti‐CD19 CAR T‐cell therapy compared to de novo Ph‐positive B cell acute lymphoblastic leukemia.

Published in:

HemaSphere, 2024, v. 8, n. 2, p. 1, doi. 10.1002/hem3.49

By:

Liu, Mei‐Jing;
Tan, Kai‐Wen;
Cao, Han‐Yu;
Huang, Si‐Man;
Qian, Chong‐Sheng;
Xue, Sheng‐Li;
Dai, Hai‐Ping;
Gong, Wen‐Jie

Publication type:

Article

Venetoclax combined with azacitidine as an effective and safe salvage regimen for relapsed or refractory T-cell acute lymphoblastic leukemia: a case series.

Published in:

2021

By:

Wan, Chao-Ling;
Zou, Jing-Ying;
Qiao, Man;
Yin, Jia;
Shen, Xiang-Dong;
Qiu, Qiao-Cheng;
Liu, Song-Bai;
Xue, Sheng-Li

Publication type:

Letter

Diagnosis and Treatment Procedures of Congenital Neutropenia.

Published in:

Journal of Experimental Hematology / Zhongguo Shiyan Xueyexue Zazhi, 2012, v. 20, n. 5, p. 1221

By:

QIAO Man;
XUE Sheng-Li;
ZOU Jing-Ying;
DAI Lan;
LIU Hui-Wen;
CHEN Yon;
SUN Ai-Ning;
WU De-Pei

Publication type:

Article

Chidamide: Targeting epigenetic regulation in the treatment of hematological malignancy.

Published in:

Hematological Oncology, 2023, v. 41, n. 3, p. 301, doi. 10.1002/hon.3088

By:

Cao, Han‐Yu;
Li, Ling;
Xue, Sheng‐Li;
Dai, Hai‐Ping

Publication type:

Article

Combination of venetoclax with BCR-ABL tyrosine kinase inhibitor as a therapeutic strategy for Philadelphia chromosome-positive leukemias.

Published in:

Hematology, 2023, v. 28, n. 1, p. 1, doi. 10.1080/16078454.2023.2237790

By:

Zou, Jing-Ying;
Huang, Si-Man;
Zhoub, Hai-Xia;
Xu, Ming-Zhu;
Sun, Ai-Ning;
Wu, De-Pei;
Xue, Sheng-Li;
Zhang, Tong-Tong

Publication type:

Article

The impact of FLT3 mutations on treatment response and survival in Chinese de novo AML patients.

Published in:

Hematology, 2018, v. 23, n. 3, p. 131, doi. 10.1080/10245332.2017.1372248

By:

Qiu, Qiao-Cheng;
Wang, Chao;
Bao, Xie-Bing;
Yang, Jing;
Shen, Hong-Jie;
Ding, Zi-Xuan;
Liu, Hong;
He, Jun;
Yao, Hong;
Chen, Su-Ning;
Li, Zheng;
Xue, Sheng-Li;
Liu, Song-Bai

Publication type:

Article

Clinical outcomes and safety of CAR-T cells in treatment of T-Cell acute lymphoblastic leukemia/lymphoma.

Published in:

Annals of Hematology, 2025, v. 104, n. 1, p. 57, doi. 10.1007/s00277-024-06132-w

By:

Ma, Jin-Feng;
Yan, Chun-Long;
Jia, Xu;
Zhu, Hong-Jia;
Yan, Jia-Wei;
Liu, Mei-Jing;
Zhang, Dai-Yi;
Liu, Shen-Hao;
Xu, Nan;
Zhang, Hai-Guo;
Ye, Ling;
Yu, Lei;
Wu, De-Pei;
Gong, Wen-Jie;
Dai, Hai-Ping;
Xue, Sheng-Li

Publication type:

Article

Chidamide combined with azacitidine as a novel double epigenetic preemptive treatment for a myelodysplastic syndrome patient showing molecular relapse after allogeneic hematopoietic stem cell transplantation.

Published in:

Annals of Hematology, 2024, v. 103, n. 12, p. 6003, doi. 10.1007/s00277-024-06137-5

By:

Liu, Fang-Tong;
Wan, Chao-Ling;
Huang, Yuan-Hong;
Cao, Han-Yu;
Lyu, Xiao-Yu;
Wang, Zi-Hao;
Huang, Si-Man;
Tan, Kai-Wen;
Ge, Shuai-Shuai;
Zhang, Yang;
Xue, Sheng-Li

Publication type:

Article

Genetic and clinical characteristics of acute B-cell lymphoblastic leukemia with MEF2D fusions and report of two novel MEF2D rearrangements.

Published in:

Annals of Hematology, 2024, v. 103, n. 10, p. 4155, doi. 10.1007/s00277-024-05868-9

By:

Cao, Han-Yu;
Li, Hui-Ying;
Cai, Wen-Zhi;
Huang, Yuan-Hong;
Qiu, Qiao-Cheng;
Li, Zheng-;
Xu, Yang;
Xue, Sheng-Li;
Dai, Hai-Ping

Publication type:

Article

Rapid molecular response to dasatinib in Ph-like acute lymphoblastic leukemia patients with ABL1 rearrangements: case series and literature review.

Published in:

Annals of Hematology, 2023, v. 102, n. 9, p. 2397, doi. 10.1007/s00277-023-05236-z

By:

Tan, Kai-Wen;
Zhu, Yi-Yan;
Qiu, Qiao-Cheng;
Wang, Man;
Shen, Hong-Jie;
Huang, Si-Man;
Cao, Han-Yu;
Wan, Chao-Ling;
Li, Yan-Yan;
Dai, Hai-Ping;
Xue, Sheng-Li

Publication type:

Article

Targeted therapy and immunotherapy for T cell acute lymphoblastic leukemia/lymphoma.

Published in:

Annals of Hematology, 2023, v. 102, n. 8, p. 2001, doi. 10.1007/s00277-023-05286-3

By:

Huang, Yuan-hong;
Wan, Chao-Ling;
Dai, Hai-ping;
Xue, Sheng-li

Publication type:

Article

Comparing the efficacy of salvage regimens for relapsed/refractory B-cell acute lymphoblastic leukaemia: a systematic review and network meta-analysis.

Published in:

Annals of Hematology, 2023, v. 102, n. 1, p. 155, doi. 10.1007/s00277-022-05040-1

By:

Cao, Han-Yu;
Wan, Chao-Ling;
Xue, Sheng-Li

Publication type:

Article

Effects of preemptive interferon-α monotherapy in acute leukemia patients with relapse tendency after allogeneic hematopoietic stem cell transplantation: a case-control study.

Published in:

2018

By:

Lin, Xiao-Ji;
Dai, Hai-Ping;
Wang, Ai-Jing;
Chen, Feng;
Ma, Xiao;
Sun, Ai-Ning;
Zhu, Xia-Ming;
Qiu, Hui-Ying;
Jin, Zheng-Min;
Miao, Miao;
Xue, Sheng-Li;
Mao, Xin-Liang;
Wu, De-Pei;
Tang, Xiao-Wen

Publication type:

journal article

Myocardial edema during chemotherapy for gynecologic malignancies: A cardiac magnetic resonance T2 mapping study.

Published in:

Frontiers in Oncology, 2022, v. 12, p. 01, doi. 10.3389/fonc.2022.961841

By:

Meng-Xi Yang;
Qing-Li Li;
Dan-Qing Wang;
Lu Ye;
Ke-Min Li;
Xiao-Juan Lin;
Xue-Sheng Li;
Chuan Fu;
Xin-Mao Ma;
Xi Liu;
Ru-Tie Yin;
Zhi-Gang Yang;
Ying-Kun Guo

Publication type:

Article

Combination of Venetoclax and Midostaurin Efficiently Suppressed Relapsed t(8;21)Acute Myeloid Leukemia With Mutant KIT After Failure of Venetoclax Plus Azacitidine Treatment.

Published in:

Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.841276

By:

Li, Zheng;
Wang, Jun;
Ge, Shuai-Shuai;
Qiu, Qiao-Cheng;
Du, Jia-Hui;
Shan, Shuang-Shuang;
Shen, Xiang-Dong;
Wan, Chao-Ling;
Wang, Bin-Ru;
Wu, De-Pei;
Qiu, Hui-Ying;
Xue, Sheng-Li

Publication type:

Article

Wide-Band Patch Antenna Array with Low Cross-Polarization Characteristics.

Published in:

Progress in Electromagnetics Research Letters, 2017, v. 71, p. 23

By:

Fei-Biao Dong;
Li-Mei Xu;
Xue-Sheng Li;
Min Chen;
Xiao-Mei Xie

Publication type:

Article

Rapid and Efficient Response to Gilteritinib and Venetoclax-Based Therapy in Two AML Patients with FLT3-ITD Mutation Unresponsive to Venetoclax Plus Azacitidine.

Published in:

OncoTargets & Therapy, 2022, v. 15, p. 159, doi. 10.2147/OTT.S336715

By:

Zhang, Lei-Si;
Wang, Jun;
Xu, Ming-Zhu;
Wu, Tian-Mei;
Huang, Si-Man;
Cao, Han-Yu;
Sun, Ai-Ning;
Liu, Song-Bai;
Xue, Sheng-Li

Publication type:

Article

Low-dose cytarabine and aclarubicin combined with granulocyte colony-stimulating factor for the treatment of relapsed or primary refractory acute lymphocytic leukemia: a retrospective study of 25 Chinese patients.

Published in:

Hematological Oncology, 2013, v. 31, n. 4, p. 206, doi. 10.1002/hon.2051

By:

Xue, Sheng‐Li;
Cui, Hong‐Xia;
Zou, Jing‐Ying;
Xue, Meng‐Xing;
Tang, Xiao‐Wen;
Zhang, Yan‐Ming;
Wu, De‐Pei

Publication type:

Article

Mutation spectrum of FLT3 and significance of non‐canonical FLT3 mutations in haematological malignancy.

Published in:

British Journal of Haematology, 2023, v. 202, n. 3, p. 539, doi. 10.1111/bjh.18877

By:

Ge, Shuai‐Shuai;
Qiu, Qiao‐Cheng;
Dai, Hai‐Ping;
Shen, Xiang‐Dong;
Wu, Tian‐Mei;
Du, Jia‐Hui;
Wan, Chao‐Ling;
Shen, Hong‐Jie;
Wu, De‐Pei;
Xue, Sheng‐Li;
Liu, Song‐Bai

Publication type:

Article

14,15β-dihydroxyklaineanone inhibits HepG2 cell proliferation and migration through p38MAPK pathway.

Published in:

Journal of Pharmacy & Pharmacology, 2021, v. 73, n. 11, p. 1165, doi. 10.1111/jphp.13289

By:

Xiao-Dong Pei;
Song-Qing He;
Li-Qun Shen;
Jing-Chen Wei;
Xue-Sheng Li;
Yan-Yan Wei;
Yu-Meng Zhang;
Xin-Yu Wang;
Feng Lin;
Zhi-Long He;
Li-He Jiang

Publication type:

Article

Preemptive inotuzumab ozogamicin eradicated measurable residual disease in Ph‐negative acute lymphoblastic leukemia relapsed post CD19 CART therapy.

Published in:

2023

By:

Huang, Si‐Man;
Wan, Chao‐Ling;
Cao, Han‐Yu;
Li, Yan‐Yan;
Qian, Chong‐Sheng;
Zhou, Hai‐Xia;
Xu, Ming‐Zhu;
Hu, Xiao‐Hui;
Dai, Lan;
Dai, Hai‐Ping;
Xue, Sheng‐Li

Publication type:

Case Study

Flumatinib plus venetoclax as an effective therapy for Philadelphia chromosome‐positive acute myeloid leukemia: A case report.

Published in:

2023

By:

Huang, Si‐Man;
Tao, Tao;
Wan, Chao‐Ling;
Wu, Tian‐Mei;
Cao, Han‐Yu;
Qiu, Yan;
Shen, Xiang‐Dong;
Wang, Bin‐Ru;
Ge, Shuai‐Shuai;
Li, Yan‐Yan;
Zhang, Tong‐Tong;
Wu, Bing;
Xue, Sheng‐Li

Publication type:

Case Study

Efficiency of anti‐VEGF therapy in central nervous system AML relapse: A case report and literature review.

Published in:

Clinical Case Reports, 2022, v. 10, n. 2, p. 1, doi. 10.1002/ccr3.5367

By:

Cao, Han‐Yu;
Tao, Tao;
Shen, Xiang‐Dong;
Bai, Lian;
Wan, Chao‐Ling;
Wu, De‐Pei;
Li, Jin‐Li;
Xue, Sheng‐Li

Publication type:

Article

Successful treatment of acute B lymphoblastic leukemia relapse in the skin and testicle by anti-CD19 CAR-T with IL-6 knocking down: a case report.

Published in:

Biomarker Research, 2020, v. 8, n. 1, p. 1, doi. 10.1186/s40364-020-00193-5

By:

Liu, Ze-Fa;
Chen, Li-Yun;
Wang, Jin;
Kang, Li-qing;
Tang, Hua;
Zhou, Yao;
Zhou, Hai-Xia;
Sun, Ai-Ning;
Wu, De-Pei;
Xue, Sheng-Li

Publication type:

Article

Phosphoproteomics profiling reveals a kinase network conferring acute myeloid leukaemia intrinsic chemoresistance and indicates HMGA1 phosphorylation as a potential influencer.

Published in:

Clinical & Translational Medicine, 2022, v. 12, n. 3, p. 1, doi. 10.1002/ctm2.749

By:

Zhu, Yinghui;
He, Xin;
Li, Shu;
Gan, Yichao;
Li, Zheng;
Wang, Hanying;
Dong, Haojie;
Zhang, Lei;
Xue, Sheng‐Li;
Xu, Yang;
Li, Ling

Publication type:

Article

The differential effects of tumor burdens on predicting the net benefits of ssCART-19 cell treatment on r/r B-ALL patients.

Published in:

Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-021-04296-3

By:

Li, Minghao;
Xue, Sheng-Li;
Tang, Xiaowen;
Xu, Jiayu;
Chen, Suning;
Han, Yue;
Qiu, Huiying;
Miao, Miao;
Xu, Nan;
Tan, Jingwen;
Kang, Liqing;
Yu, Zhou;
Lou, Xiaoyan;
Xu, Yang;
Chen, Jia;
Yan, Zhiqiang;
Feng, Weixing;
Wu, Depei;
Yu, Lei

Publication type:

Article

The Clinical and Molecular Characteristics of FLT3 Mutations in Chinese De Novo Adolescent and Adult Acute Lymphoblastic Leukemia Patients.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2020, v. 20, n. 6, p. e259, doi. 10.1016/j.clml.2019.09.602

By:

Shen, Zhen;
Chu, Xiao-Ling;
Wang, Rong-Xian;
Li, Jin-Li;
Liu, Meng-Yao;
Xie, Yi-Yu;
Wang, Chao;
Han, Rong;
Yu, Jing-Qiu;
Wang, Jun;
Tao, Tao;
Shen, Hong-Jie;
Chen, Su-Ning;
Wu, De-Pei;
Qiu, Qiao-Cheng;
Liu, Song-Bai;
Xue, Sheng-Li

Publication type:

Article

The Clinical and Molecular Characteristics of FLT3 Mutations in Chinese De Novo Adolescent and Adult Acute Lymphoblastic Leukemia Patients.

Published in:

2019

By:

Shen, Zhen;
Chu, Xiao-Ling;
Wang, Rong-Xian;
Li, Jin-Li;
Liu, Meng-Yao;
Xie, Yi-Yu;
Wang, Chao;
Han, Rong;
Yu, Jing-Qiu;
Wang, Jun;
Tao, Tao;
Shen, Hong-Jie;
Chen, Su-Ning;
Wu, De-Pei;
Qiu, Qiao-Cheng;
Liu, Song-Bai;
Xue, Sheng-Li

Publication type:

journal article

The Role of FLT3-ITD Mutation on de Novo MDS in Chinese Population.

Published in:

2019

By:

Xu, Fei;
Han, Rong;
Zhang, Jian;
Li, Zheng;
Wang, Jun;
Chu, Xiao-Ling;
Yu, Jing-Qiu;
Wang, Chao;
Tao, Tao;
Shen, Hong-Jie;
Chen, Su-Ning;
Wu, De-Pei;
Liu, Song-Bai;
Qiu, Qiao-Cheng;
Xue, Sheng-Li

Publication type:

journal article

Identification of specific biomarkers for gastric adenocarcinoma by ITRAQ proteomic approach.

Published in:

Scientific Reports, 2016, p. 38871, doi. 10.1038/srep38871

By:

Wang, Xiaoxiao;
Zhi, Qiaoming;
Liu, Songbai;
Xue, Sheng-Li;
Shen, Congcong;
Li, Yangxin;
Wu, Chaofan;
Tang, Zaixiang;
Chen, Weichang;
Song, Jenny Lee;
Bao, Meiyu;
Song, Yao-Hua;
Zhou, Jin

Publication type:

Article